[HTML][HTML] A catalytic domain variant of mitofusin requiring a wildtype paralog for function uncouples mitochondrial outer-membrane tethering and fusion
EA Engelhart, S Hoppins - Journal of Biological Chemistry, 2019 - ASBMB
Mitofusins (Mfns) are dynamin-related GTPases that mediate mitochondrial outer-membrane
fusion, a process that is required for mitochondrial and cellular health. In Mfn1 and Mfn2 …
fusion, a process that is required for mitochondrial and cellular health. In Mfn1 and Mfn2 …
Defective nucleotide-dependent assembly and membrane fusion in Mfn2 CMT2A variants improved by Bax
NB Samanas, EA Engelhart… - Life Science …, 2020 - life-science-alliance.org
Mitofusins are members of the dynamin-related protein family of large GTPases that harness
the energy from nucleotide hydrolysis to remodel membranes. Mitofusins possess four …
the energy from nucleotide hydrolysis to remodel membranes. Mitofusins possess four …
[HTML][HTML] Machine learning optimization of candidate antibody yields highly diverse sub-nanomolar affinity antibody libraries
…, J Spaeth, L Shing, R Jaimes, E Engelhart… - Nature …, 2023 - nature.com
Therapeutic antibodies are an important and rapidly growing drug modality. However, the
design and discovery of early-stage antibody therapeutics remain a time and cost-intensive …
design and discovery of early-stage antibody therapeutics remain a time and cost-intensive …
Insights into the molecular mechanisms of mitochondrial outer membrane tethering and fusion
EA Engelhart - 2019 - digital.lib.washington.edu
Mitochondrial dynamics are crucial for cellular health as perturbations in these processes
which include mitochondrial fusion, division, transport and mitophagy are associated with …
which include mitochondrial fusion, division, transport and mitophagy are associated with …
Massively multiplexed affinity characterization of therapeutic antibodies against SARS-CoV-2 variants
Antibody therapies represent a valuable tool to reduce COVID-19 deaths and hospitalizations.
Multiple antibody candidates have been granted emergency use authorization by the …
Multiple antibody candidates have been granted emergency use authorization by the …
[HTML][HTML] A dataset comprised of binding interactions for 104,972 antibodies against a SARS-CoV-2 peptide
The dataset presented here contains quantitative binding scores of scFv-format antibodies
against a SARS-CoV-2 target peptide collected via an AlphaSeq assay that can be used in …
against a SARS-CoV-2 target peptide collected via an AlphaSeq assay that can be used in …
High-throughput ML-guided design of diverse single-domain antibodies against SARS-CoV-2
C Angermueller, Z Mariet, B Jester, E Engelhart… - bioRxiv, 2023 - biorxiv.org
Treating rapidly evolving pathogenic diseases such as COVID-19 requires a therapeutic
approach that accommodates the emergence of viral variants over time. Our machine learning (…
approach that accommodates the emergence of viral variants over time. Our machine learning (…
Massively Multiplexed Affinity Characterization of Therapeutic Antibodies Against SARS-CoV-2 Variants (preprint)
Antibody therapies represent a valuable tool to reduce COVID-19 deaths and hospitalizations.
Multiple antibody candidates have been granted emergency use authorization by the FDA …
Multiple antibody candidates have been granted emergency use authorization by the FDA …
1198 Cytokine affinity tuning and antibody discovery/optimization using the AlphaSeq and AlphaBind platforms to generate targeted immuno-oncology therapeutics
…, K Wellman, J Marken, J Adamo, E Engelhart… - J …, 2023 - scholar.archive.org
Background Although cytokine therapies have demonstrated curative effects in some cancer
patients, clinical use remains limited due to inflammatory toxicity profiles accompanying …
patients, clinical use remains limited due to inflammatory toxicity profiles accompanying …
Abstract LB333: Cytokine affinity tuning using the AlphaSeq platform to generate targeted immuno-oncology therapeutics
…, D Goodnight, J Adamo, K Minch, E Engelhart… - Cancer Research, 2023 - AACR
Here, we demonstrate a novel approach for generating affinity detuned cytokines that can
be fused to antibodies for selective immune cell activation to improve anti-tumor responses …
be fused to antibodies for selective immune cell activation to improve anti-tumor responses …